ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Deoxynojirimycin → Deoxynojirimycin

HRID 1357023
印刷

反応式

HRID 1357023 の反応式
[CH2:1]1[NH:6][C@H:5]([CH2:7][OH:8])[C@@H:4]([OH:9])[C@H:3]([OH:10])[C@H:2]1[OH:11].[CH2:12]1[NH:17][C@H:16]([CH2:18][OH:19])[C@H:15]([OH:20])[C@H:14]([OH:21])[C@H:13]1[OH:22].C1[C@@H:28]([OH:29])[C@H](O)[C@@H](CO)NC1>>[CH2:1]1[NH:6][C@H:5]([CH2:7][OH:8])[C@@H:4]([OH:9])[C@H:3]([OH:10])[C@H:2]1[OH:11].[CH2:28]([OH:29])[C@H:12]1[NH:17][C@H:16]([CH2:18][OH:19])[C@H:15]([OH:20])[C@@H:14]([OH:21])[C@@H:13]1[OH:22].[CH2:18]([OH:19])[C@H:1]1[NH:6][C@H:5]([CH2:7][OH:8])[C@@H:4]([OH:9])[CH:3]([OH:10])[C@@H:2]1[OH:11].[CH2:18]([OH:19])[C@H:1]1[NH:6][C@H:5]([CH2:7][OH:8])[C@H:4]([OH:9])[CH:3]([OH:10])[C@@H:2]1[OH:11]
参加物実験手順出典と根拠反応ノート

参加物

7

反応物 3

HCID 29435DeoxynojirimycinHCID 72259FagomineHCID 176077Migalastat

生成物 4

HCID 29435DeoxynojirimycinHCID 159496(2r,3r,5s,6r)-2,6-Bis(hydroxymethyl)piperidine-3,4,5-triolHCID 195553Homomannojirimycin
HCID 178521053
HCID 178521053、化合物

実験手順

1-deoxynojirimycin (DNJ) (1) was isolated from the roots of Morus alba (Moraceae) as described previously (28). 1-Deoxymannojirimycin (manno-DNJ) (2) and 1-deoxy-3,4-diepi-nojirimycin (gulo-DNJ) (5) have been recently isolated from the barks of Angylocalyx pynaertii (Leguminosae). 1-Deoxy-3-epi-nojirimycin (allo-DNJ) (3) was prepared by the microbial redox reaction at C-3 of the N-benzyloxycarbonyl derivative of DNJ as described previously (29) 1-Deoxygalactonojirimycin (DGJ) (4) and 1,2-dideoxy-galactonojirimycin (6) were prepared by the chemical epimerization of the 4-OH group 1 and fagomine, respectively, according to the literature procedure (30). α-Homonojirimycin (α-HNJ) (7), α-homomannojirimycin (α-manno-HNJ) (8), and α-homoallonojirimycin (α-allo-HNJ) (9) were isolated from the whole plant of Aglaonema treubii (Araceae) as reported previously (31). α-Homogalactonojirimycin(α-galacto-HNJ) (10) was prepared from 2,3,4,6-tetra-O-benzyl -D-galactose by way of a Wittig chain extension and a mercuricyclization according to the literature procedure (33). N-Methyl-DGJ (11) was prepared by treatment of 4 with 37% HCHO and 80% formic acid according to the reference (34), and the N-ethyl (12), N-propyl (13), N-butyl (14) and N-hydroxyethyl (15) derivatives of 4 were prepared by treatment with the appropriate alkyl bromide and triethylamine in DMF. The reaction mixture of N-alkylation was evaporated in vacuo, and the residual syrup was resolved in MeOH and applied to an Amberlyst 15 column (H+ form), washed with MeOH, eluted with 0.5 M NH4OH, and concentrated. N-Alkylated derivatives were finally purified by Dowex 1×2 (OH form) and Amberlite CG-50 (NH4+ form) chromatography with as eluent. β-1-C-Butyl-DGJ (16) was isolated from Adenophorae Radix as described previously (35). 4-epi-isofagomine (21), isofagomine (33) and its derivatives (34-37) were chemically synthesized as described previously (40). 2,5-Dideoxy-2,5-imino-D-mannitol (DMDP, 27), 1,4-dideoxy-1,4-imino-D-arabinitol (DAB, 28) were purified from Dermis malaccensis and Morus alba, respectively (29). N-butyl-DNJ (30), N-dodecyl-DNJ (31), castanospermine (29) were from commercial sources. Calystegine A3 (17), calystegine A5 (22), calystegine B1 (23), calystegine B2 (18), calystegine B3 (24), calystegine B4 (25), and calystegine C1 (26) were prepared as published method (36, 40a), N-methyl calystegine A3 (19) and N-methyl calystegine B2 (20) were chemically synthesized. Structural characterization of some inhibitors The structural characterization of the inhibitors is determined by mass spectrometry and 13C-NMR, and some of the results are presented below.

出典と根拠

ORDレコード
ord-be1082d028424aaea30507463cb447fb
出典データセット
uspto-grants-2003_07
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US06589964B2

反応ノート

このページの内容参加物実験手順出典と根拠反応ノート